Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sling failures: what's next?

Harriette M Scarpero1, Roger R Dmochowski

  • 1Department of Urologic Surgery, Vanderbilt University, Nashville, TN 37232, USA. harriette.scarpero@vanderbilt.edu

Current Urology Reports
|October 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urobiome Analysis in Interstitial Cystitis/Bladder Pain Syndrome Reveals Nuanced Differences Associated with Localized Pain.

International urogynecology journal·2026
Same author

Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study.

Minerva urology and nephrology·2026
Same author

Cost-utility of implantable tibial neuromodulation (Revi) versus conservative therapy for urgency urinary incontinence in adults: a US payer perspective.

Journal of medical economics·2026
Same author

Three-Year Efficacy and Safety of Revi Implantable Tibial Neuromodulation from the Pivotal OASIS Study.

The Journal of urology·2026
Same author

Impact of Revi® Implantable Tibial Neuromodulation on Quality of Life in Patients with Urgency Urinary Incontinence.

International urogynecology journal·2026
Same author

Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladder.

Journal of comparative effectiveness research·2025

Pubovaginal slings treat stress urinary incontinence but cause morbidity. Newer, less invasive midurethral slings are common, and even sling failures can often be treated effectively with these modern approaches.

Area of Science:

  • Urology
  • Gynecology
  • Female Pelvic Medicine

Background:

  • Pubovaginal slings are a long-standing treatment for stress urinary incontinence (SUI).
  • Surgical morbidity and voiding dysfunction are drawbacks of traditional pubovaginal slings.
  • Modifications like midurethral slings aim to decrease operative time and morbidity.

Purpose of the Study:

  • To review the evolution of sling procedures for SUI.
  • To discuss the management of sling failures.
  • To highlight the efficacy of less invasive techniques for recurrent SUI.

Main Methods:

  • Review of recent literature on sling procedures for SUI.
  • Analysis of outcomes for primary and recurrent SUI.
  • Comparison of traditional and minimally invasive sling techniques.

Related Experiment Videos

Main Results:

  • Midurethral slings are now the most common procedure for SUI due to their less invasive nature.
  • Despite widespread use, consensus on managing sling failures is lacking.
  • Recurrent SUI from sling failure can be successfully treated with less invasive techniques.

Conclusions:

  • While traditional slings have limitations, advancements have led to less invasive and effective treatments for SUI.
  • Less invasive approaches are effective for both primary and recurrent SUI, including cases of sling failure.
  • Further research may clarify optimal management strategies for sling-related complications.